Intraoperative high-dose-rate brachytherapy for the treatment of pediatric tumors: The Ohio State University experience

被引:31
作者
Nag, S
Tippin, D
Ruymann, FB
机构
[1] Ohio State Univ, Arthur G James Canc Hosp, Dept Clin Radiol, Columbus, OH 43210 USA
[2] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA
[3] Ohio State Univ, Childrens Hosp, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 51卷 / 03期
关键词
pediatric; brachytherapy; radiation therapy; intraoperative; high-dose rate;
D O I
10.1016/S0360-3016(01)01697-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine whether intraoperative high-dose-rate brachytherapy (IO-HDRBT) can be used to decrease the dose of external beam radiotherapy (EBRT) in the treatment of children with soft-tissue sarcomas and, thereby, reduce morbidity without compromising local control. Methods and Materials: From March 1992 through April 1999, 13 pediatric patients were treated with IO-HDRBT, low-dose EBRT, chemotherapy, and radical surgery at 21 sites that were not amenable to intraoperative electron beam therapy. The IO-HDRBT dose at 5 mm depth was 10 to 12.5 Gy for close margins/microscopic disease at 14 sites and 12.5 to 15 Gy for gross disease at 7 sites. The treatment volumes ranged from 4 to 96 cm(3) (mean 27). The EBRT dose was limited to 27-30 Gy in most cases to minimize growth retardation and preserve normal organ function. Results: After a median follow-up of 47 months (range 12-97), 11 patients were alive and without evidence of disease (overall survival rate 85%, 4-year actuarial survival rate 77%). Of the 2 who died, 1 had Stage III pulmonary blastoma with a sacral recurrence; the other had Stage IV undifferentiated synovial sarcoma with a pulmonary recurrence. One local failure occurred in a patient with gross residual disease after incomplete resection for Stage IV pulmonary blastoma. The local control rate was 95%, and morbidity was observed in 3 patients (23%). One patient developed impaired orbital growth with mild ptosis. Another patient required orthopedic pinning of her femoral subcapital epiphysis and construction of a neobladder secondary to urethral obstruction. The third patient required reimplantation of her autotransplanted kidney secondary to chronic urinary tract infection and ureteral reflux. Conclusions: IO-HDRBT allowed for reduction in EBRT without compromising local control or disease-free survival in children with soft-tissue sarcomas. Tumor beds inaccessible to electron beam methods could be satisfactorily encompassed with IO-HDRBT techniques. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:729 / 735
页数:7
相关论文
共 18 条
[1]  
CHERLOW JM, 1990, AM J PEDIAT HEMATOL, V2, P155
[2]  
CONSTINE LS, 1994, SURVIVORS CHILDHOOD, P21
[3]  
FONTANESI J, 1994, CANCER-AM CANCER SOC, V74, P733, DOI 10.1002/1097-0142(19940715)74:2<733::AID-CNCR2820740229>3.0.CO
[4]  
2-A
[5]  
GERBAULET A, 1985, CANCER, V56, P1274, DOI 10.1002/1097-0142(19850915)56:6<1274::AID-CNCR2820560609>3.0.CO
[6]  
2-8
[7]  
GERBAULET AP, 1989, INT J RADIAT ONCOL, V16, P655
[8]  
HALPERIN EC, 1999, PEDIAT RAD ONCOLOGY, P457
[9]   A 10-YEAR EXPERIENCE OF PEDIATRIC BRACHYTHERAPY [J].
HEALEY, EA ;
SHAMBERGER, RC ;
GRIER, HE ;
LOEFFLER, JS ;
TARBELL, NJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (02) :451-455
[10]  
Merchant TE, 1998, MED PEDIATR ONCOL, V30, P34